Defactinib and Avutometinib, With or Without Encorafenib, for the Treatment of Patients With Brain Metastases From Cutaneous Melanoma

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Cutaneous Melanoma · Brain Metastases

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Iowa, Iowa City, Iowa, United States
Contact: Study coordinator (Mohammed Milhem, MD) · 319-356-2324
Contact: Principal Investigator (Mohammed Milhem, MD)
Huntsman Cancer Institute, Salt Lake City, Utah, United States
Contact: Study coordinator (Rachel Kingsford) · rachel.kingsford@hci.utah.edu · 801-585-0115
Contact: Principal Investigator (Howard Colman, MD, PhD)

Study leads

Howard Colman, MD, PhD
Principal Investigator
Huntsman Cancer Institute/ University of Utah

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Trial of Relatlimab, Nivolumab, and Ipilimumab in Patients With Asymptomatic and Symptomatic Melanoma Brain Metastases

Melanoma · Brain Metastases

Abroad (travel likely)RecruitingPHASE2

Palo Alto, United States

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Melanoma · Non-small Cell Lung Cancer · Squamous Cell Carcinoma (Skin)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Grand Rapids, United States · St Louis, United States

Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma

Cutaneous Melanoma · Melanoma Stage IV · Mucosal Melanoma

Abroad (travel likely)RecruitingPHASE2

Toronto, Canada

Patient Preference for Subcutaneous vs. Intravenous Immune Therapy

Renal Cell Carcinoma · Non Small Cell Lung Cancer · Melanoma

Abroad (travel likely)RecruitingPHASE2

Pittsburgh, United States